Current role
Kevin M. O'Neill
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kevin M. O'Neill
GE HealthCare Technologies Inc. reported in an 8-K filed January 4, 2023 that Kevin M. O'Neill was appointed CEO, Pharmaceutical Diagnostics, effective January 3, 2023.
“As previously reported in the Information Statement, effective as of 5:00 p.m. Eastern time on the Distribution Date, the following persons were appointed as executive officers of the Company serving in the offices of the Company set forth beside each person's name:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at GE HealthCare Technologies Inc.
Other people whose current roles at this company are on record from its filings.
- Peter J. Arduini CEO, Board Member
- Catherine Lesjak Chairman, Board Member
- George Newcomb CFO, Chief Accounting Officer
- James K. (Jay) Saccaro CFO
- William K. Grogan CFO
- Frank R. Jimenez General Counsel
- George A. Newcomb Chief Accounting Officer
- Anne T. Madden Board Member
- H. Lawrence Culp, Jr. Board Member
- Kevin A. Lobo Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.